|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2006;81:1337-1338
© 2006 The Society of Thoracic Surgeons
Department of Cardiothoracic Surgery, University of Massachusetts, 55 Lake Ave N, S3-747, Worcester, MA 01655
(Email: adam.saltman@umassmed.edu).
The use of ablative technologies during the last few years has allowed the cardiac surgeon to treat many more patients who present to the operating room with atrial fibrillation. Although patients with mitral valve disease have been the most extensively studied, patients with coronary disease clearly comprise the largest absolute number of cases presenting to the surgeon. Akpinar and colleagues [1] have nicely shown in this article that this group of patients can undergo ablation in an off-pump setting both safely and effectively.
However the authors have
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |